Loading clinical trials...

A Screening Study to Detect BRAF V600 Mutation-Positive Patients For Enrollment Into Clinical Research Studies of Zelboraf (Vemurafenib) | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT01804140

A Screening Study to Detect BRAF V600 Mutation-Positive Patients For Enrollment Into Clinical Research Studies of Zelboraf (Vemurafenib)

This is a screening study to detect BRAF V600 mutation-positive patients for enrollment into clinical research studies of Zelboraf (vemurafenib). Tumor samples will be collected and analyzed from elig...

Lead sponsor: Genentech, Inc.•20 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGPhase 4

Fenofibrate Role in the Prophylaxis From Peripheral Neuropathy Induced by Bortezomib, Lenalidomide and Dexamethasone (VRd) Protocol in the Treatment of Patients With Multiple Myeloma (MM)

NCT07025005 · Peripheral Neuropathy, Multiple Myeloma, Neoplasms

COMPLETEDPhase 2

A Study of Vemurafenib in Participants With BRAF V600 Mutation-Positive Cancers

NCT01524978 · Multiple Myeloma, Neoplasms

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 2, 2016Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment662

Start dateDec 2012

Last updatedNov 2, 2016

Condition

Multiple Myeloma, Neoplasms

Locations shown

Sedona, Arizona

Tucson, Arizona

Burbank, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 2, 2016Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions